169170 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types Neurological cells
LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
#602Methods and compositions for translational profiling and molecular phenotyping
#603Neurofibromatoses therapeutic agents and screening for same
#604In vitro model for neuronal death
#605PROCESS AND DEVICE FOR THE DETERMINATION OF ALTERATIONS IN NEURONAL CONNECTIVITY AND/OR MORPHOLOGY
#606Transgenic animal model of mood disorders
#607Identification of olfactory receptors sensitive to different odorants
#608Optically sensitive cell network
#609GENERATION OF PHOTORECEPTORS FROM HUMAN RETINAL PROGENITOR CELLS USING POLYCAPROLACTONE SUBSTRATES
#610Therapeutic curcumin derivatives
#611Methods of identifying, isolating and using odorant and aroma receptors
#612COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
#613Pluripotent cell lines and methods of use thereof
#614Methods for inducing orexin neurons and agent for treating narcolepsy or eating disorder
#615Synthetic mammalian neuromuscular junction and method of screening for a candidate drug thereon
#616Methods for producing retinal tissue and retina-related cell
#617Inducible cell-based model for the study of Friedreich's Ataxia
#618Channelrhodopsins for optical control of cells
#619Botulinum Neurotoxin E Receptors and Uses Thereof
#620NEURODEGENERATIVE DISEASES AND METHODS OF MODELING
#621Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS
#622PKC activators and combinations thereof
#623High MAST2-affinity polypeptides and uses thereof
#624Coated fiber scaffold for three dimensional cell culture of neural cells
#625Prevention or attenuation of neuropathic pain by bile acids
#626METHOD OF IDENTIFYING AGENTS THAT AFFECT MATURATION, SURVIVAL AND MYELINATION
#627METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE BY ADMINISTERING AN ANTI-ANGIOGENIC AGENT
#628In vivo cellular screening methods and compositions for modeling and treating nervous system dysfunction
#629BIOMARKERS
#630Whole brain lysate antigen-specific memory B cell and antibody assays in multiple sclerosis
#631Method for producing insoluble aggregate of neurodegenerative-disease-related protein
#632Stable Electrically Active Neurons from Adult Tissue
#633Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide
#634Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells
#635HUMAN INDUCED NEURONAL CELLS
#636Method for identifying a malodor inhibitor
#637Neurogenesis screening method and uses thereof
#638SCREENING METHODS BASED ON VESICLE MOBILITY
#639IDENTIFICATION AND USE OF ANXIOLYTIC COMPOUNDS
#640Methods of reducing levels of tau
#641Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease
#642Insect-based ex vivo model for testing blood-brain barrier penetration and method for exposing insect brain to nanoparticles
#643Compositions to effect neuronal growth
#644Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same
#645Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy
#646Anti-human receptor-type protein tyrosine phosphatase sigma antibody
#647TDP-43-storing cell model
#648Control and Characterization of Psychotic States
#649Identification of compounds that disperse TDP-43 inclusions
#650Therapeutic applications targeting SARM1
#651Microfluidic biological barrier model and associated method
#652Agents that reduce neuronal overexcitation
#653Device for high throughput investigations of multi-cellular interactions
#654Methods of screening compounds for the fibril formation of Aβ peptides based on a decreased trimer/monomer ratio of a chaperone protein
#655METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES
#656Alzheimer's Disease Cellular Model for Diagnostic and Therapeutic Development
#657Cell-Based Models of Neurodegenerative Disease
#658Method of regulating neuronal axon elongation
#659NOGO receptor binding protein
#660BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
#661Method for determining activators of excitatory synapse formation
#662Compositions and methods for treating cancer and neurodegenerative diseases
#663GREEN TEA POLYPHENOL ALPHA SECRETASE ENHANCERS AND METHODS OF USE
#664Light-activated chimeric opsins and methods of using the same
#665NEUROGENESIS SCREENING METHOD AND SYSTEM USING ADIPOSE TISSUE DERIVED STEM CELLS
#666Method for searching for malodor control agent, malodor control agent, and malodor control method
#667Microfluidic device for generating neural cells to simulate post-stroke conditions
#668Wound healing metakaryotic stem cells and methods of use thereof
#669GENERATION OF PHOTORECEPTORS FROM HUMAN RETINAL PROGENITOR CELLS USING POLYCAPROLACTONE SUBSTRATES
#670Delivery of nanoparticles to neurons
#671Methods for enhancing neprilysin activity and degrading amyloid-beta peptides and oligomers in a subject with Alzheimer's disease
#672Model and methods for identifying points of action in electrically active cells
#673Method of identifying transmembrane protein-interacting compounds
#674Dopaminergic neuronal survival-promoting factors and uses thereof
#675METHOD AND APPARATUS FOR REMOVING NOXIOUS MATERIALS FROM CELLS
#676PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASE AND METHOD OF SCREENING THE SAME
#677METHOD FOR DISCOVERING NEUROGENIC AGENTS
#678Blood-Brain Barrier Model
#679Compounds for the treatment of autism
#680Direct conversion of cells to cells of other lineages
#681Reporter system for high throughput screening of compounds and uses thereof
#682Method for preparing an X chromosome inactivated female human neural cell
#683Dynactin subunit p62 biomarker for neurological conditions
#684Therapeutic Applications Targeting SARM1
#685Modulation of synaptic maintenance
#686Lineage Restricted Glial Precursors from the Central Nervous System
#687METHODS OF CONTROLLING AXON OR DENDRITE DEVELOPMENT OF NEURONAL CELLS
#688USE OF TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROLACTINOMA
#689Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells
#690MicroRNA Mediated Neuronal Cell Induction
#691In Vitro Model Of Spinal Muscular Atrophy
#692COMPOUNDS FOR ALLEVIATING PAIN AND STRESS IN FETUS AND NEWBORN
#693Dopaminergic neuron progenitor cell marker 187A5
#694METHODS FOR TREATING NEURAL CELL SWELLING
#695Lipophilic dye-based FRET assays for clostridial toxin activity
#696METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#697NOGO receptor binding protein
#698Chinese Herbal Aqueous Extract Having Anti-Anxiety Activities and Method of In Vitro Evaluating the Same
#699Cells useful for immuno-based botulinum toxin serotype A activity assays
#700Cells useful for immuno-based botulinum toxin serotype A activity assays
#701METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING sAPPbeta
#702Cells useful for immuno-based botulinum toxin serotype A activity assays
#703Cells useful for immuno-based botulinum toxin serotype A activity assays
#704Agents that reduce neuronal overexcitation
#705Modulation of synaptic maintenance
#706Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
#707Method of detection using antibodies that specifically bind hedgehog-derived polypeptides
#708Anti-ADDL antibodies and uses thereof
#709Screening methods for cognitive enhancers
#710TREATMENT OF NEURODEGENERATION AND NEUROINFLAMMATION
#711Cells useful for immuno-based botulinum toxin serotype A activity assays
#712Cells useful for immuno-based botulinum toxin serotype A activity assays
#713Cells useful for immuno-based botulinum toxin serotype A activity assays
#714Cells useful for immuno-based botulinum toxin serotype A activity assays
#715Cells useful for immuno-based Botulinum toxin serotype A activity assays
#716Method and Pharmaceutical Composition for Use in the Treatment of Neurodegenerative Disorders
#717Cells useful for immuno-based botulinum toxin serotype A activity assays
#718Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
#719Cells useful for immuno-based botulinum toxin serotype A activity assays
#720Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
#721Composition and method for treating a tauopathy
#722Caged Neuropeptides: modulation and measurement of synapse and signaling activity; and methods for drug evaluation, pharmaceuticals preparation and treatment
#723PHARMACEUTICAL COMPOSITION CONTAINING NUCLEAR FACTOR INVOLVED IN PROLIFERATION AND DIFFERENTIATION OF CENTRAL NEURONAL CELLS
#724SCHIZOPHRENIA METHODS AND COMPOSITIONS
#725Evaluation of the potential risk of drug induced mood disturbance and suicide: use of a dedicated platform
#726TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF
#727ACCELERATED EXTENSION OF AXONS
#728MODULATION OF SEROTONIN NEURONS INVOLVING THE PET-1 TRANSCRIPTIONAL CONTROL REGION
#729ALTERING MEMORY BY AFFECTING STAUFEN FUNCTION
#730Compositions for promoting epigenetic DNA demethylation and methods of use therefore
#731METHOD FOR ANALYSIS OF NEURITE GROWTH
#732Novel Target for Regulating Multiple Sclerosis
#733Methods for identifying safe and functional humanized antibodies
#734SYNAPTIC VESICLE CYCLING ASSAYS AND SYSTEMS
#735Multipotent neural stem cells
#736Directed differentiation of primate pluripotent stem cells into functional basal forebrain cholinergic neurons (BFCNs) and medium spiny gabaergic projection neurons
#737IDENTIFICATION, DIAGNOSIS, AND TREATMENT OF NEUROPATHOLOGIES, NEUROTOXICITIES, TUMORS, AND BRAIN AND SPINAL CORD INJURIES USING ELECTRODES WITH MICROVOLTAMMETRY
#738Compositions to effect neuronal growth
#739Polypeptides for Specific Targeting to Otx2 Target Cells
#740METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND DISEASES
#741IDENTIFICATION OF NEUROPROTECTIVE AGENTS USING PRO-INFLAMMATORY HUMAN GLIAL CELLS
#742Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders
#743Blood-brain barrier model
#744High throughput assays for transmissible spongiform encephalopathies (TSE)
#745In vitro test system for viral infections
#746ASSAY FOR SCREENING ANTIDEPRESSANTS
#747ATF4 inhibitors and their use for neural protection, repair, regeneration, and plasticity
#748Genetic Alterations Associated with Schizophrenia and Methods of Use Thereof for the Diagnosis and Treatment of the Same
#749CO-CULTURE COMPOSITIONS AND METHODS
#750Method for Detecting Soluble Amyloid Precursor Protein (APP) Alpha and/or Soluble APP Beta
#751Modulation of axon degeneration
#752Formation of neuromuscular junctions in a co-culture comprising rat muscle cells overlayered with differentiated human spinal cord stem cells in a serum free medium
#753Isolated transgenic mammalian neural cell for detection of a sample containing a chemical substance damage to neurological system or selection of drugs for treating neurodegenerative disorders
#754Use of Induced Pluripotent Cells and other Cells for Screening Compound Libraries
#755Method and Medium for Neural Differentiation of Pluripotent Cells
#756METHOD FOR SCREENING FOR COMPOUNDS THAT INHIBIT NEURODEGENERATION
#757Modulation of Microglia Activation
#758Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery
#759Modulation of neural stem cells and neural progenitor cells
#760MODULATION OF GM98 (MRF) IN REMYELINATION
#761Anti-ADDL antibodies and uses thereof
#762Compositions to effect neuronal growth
#763IDENTIFICATION OF A MOLECULAR SIGNATURE FOR ANTIPSYCHOTICS AND SERMS
#764Compositions and Methods for the Treatment and Diagnosis of Cancer
#765Treatment of neuropathic pain using anti-thrombospondin antibodies
#766EphA4 Polypeptide Having a Novel Activity and Use Thereof
#767METHOD OF UPREGULATING SORLA FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#768Cell cycle regulation and differentiation
#769COMPOSITIONS AND METHODS OF TREATMENT USING MODULATORS OF MOTONEURON DISEASES
#770GENES, METHODS, AND COMPOSITIONS RELATED TO NEUROGENESIS AND ITS MODULATION
#771METHODS AND COMPOSITIONS FOR TRANSLATIONAL PROFILING AND MOLECULAR PHENOTYPING
#772Nogo Receptor Binding Small Molecules to Promote Axonal Growth
#773Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneration by an orthodenticle HOMOLOG2 (OTX2) homeoprotein
#774NOVEL TOOL FOR THE ANALYSIS OF NEURAL CIRCUITS
#775Treating myelin diseases with optimized cell preparations
#776Peripheral zone tumor cells, methods for their preparation and use
#777Compositions to effect neuronal growth
#778ALTERING MEMORY BY AFFECTING STAUFEN
#779TDP-43-storing cell model
#780METHOD FOR IN VITRO TESTING OF COMPOUNDS FOR ASSESSING THERAPEUTIC VALUE IN THE TREATMENT OF MULTIPLE SCLEROSIS AND OTHER DISEASES WHEREIN FOAMY CELLS ARE INVOLVED IN THE DISEASE ETIOLOGY
#781Method of bioassaying yokukansan
#782TAU PROTEIN SCREENING ASSAY
#783Methods of suppressing microglial activation
#784Histidine related compounds for identifying and blocking amyloid beta ion channels
#785Neuronal cells cultured on microparticles and methods of using the neuronal cells
#786Dopaminergic neuron progenitor cell marker 187A5
#787Cell-enzyme based biosensors
#788Compositions and Methods to Promote Neural Cell Growth
#789Antibodies that specifically bind hedgehog-derived polypeptides
#790Method for identifying compounds for treatment of pain
#791METHODS FOR TREATMENT AND DIAGNOSIS OF PSYCHIATRIC DISORDERS
#792Manipulation of brain CDP-diacylglycerol and uses thereof
#793Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
#794SIGNALING INTERMEDIATES IN AN IN VITRO MODEL OF ALZHEIMER'S DISEASE
#795Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
#796GABA neuron progenitor cell marker 65B13
#797NEURITE OUTGROWTH AS AN ASSAY FOR MEMORY ENHANCING COMPOUNDS
#798In vitro model of spinal muscular atrophy
#799Method of identifying transmembrane protein-interacting compounds
#800In-Vitro Model of Blood-Brain Barrier, In-Vitro Model of Diseased Blood-Brain Barrier, and Drug Screening Method, Analysis Method for Functions of Diseased Blood-Brain Barrier, and Analysis Method for Pathogenesis Using the Same
#801Anti-ADDL antibodies and uses thereof
#802Methods of Identifying Improved NMDA Receptor Antagonists
#803Formation/elongation of axon by inhibiting the expression or function of Singar and application to nerve regeneration
#804IN VIVO MODULATION OF NEURONAL TRANSPORT
#805Benzimidazole-carboxamide compounds as 5-HTreceptor agonists
#806Indole and indoline derivatives and methods of use thereof
#807METHODS AND KITS FOR IDENTIFICATION OF ANTI-EXCITOTOXIC COMPOUNDS
#808Anti-ADDL monoclonal antibody and use thereof
#809Use of Nestafin-1 in the Treatment for Diabetes
#810Cells useful for immuno-based Botulinum toxin serotype A activity assays
#811Insect repellent and attractants
#812MODULATORS OF ODORANT RECEPTORS
#813METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING sAPPbeta
#814Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds
#815Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis
#816Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds
#817PHOTO-ELECTRIC DEVICE AND METHOD FOR HIGH THROUGHPUT ACTIVATION, GUIDANCE AND PORATION OF TARGETED CELLS WITH HIGH SPATIAL RESOLUTION
#818Methods for diagnosis and monitoring of neurological disease by detection of an excephalotoxin
#819Nogo receptor binding protein
#820Method of bioassaying yokukansan
#821Method of Inducing Cleavage of Amyloid Precursor Protein to Form a Novel Fragment
#822Pluripotent cell lines and methods of use thereof
#823Multi-stage stem cell carcinogenesis
#824Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates
#825Altering memory by affecting staufen function
#826Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds
#827Treatment of autism spectrum disorders with agents that activate the Locus Coeruleus-Noradrenergic system
#828Dopaminergic neuronal survival-promoting factors and uses thereof
#829Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta
#830METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#831CANCER STEM CELLS AND USES THEREOF
#832Botulinum neurotoxin E receptors and uses thereof
#833Molecular Targets for Treatment of Learning and Memory Dysfunction
#834Peptides for the regulation of neurotransmitter sequestration and release
#835Indole and indoline derivatives and methods of use thereof
#836p75NTR MEDIATES EPHRIN-A REVERSE SIGNALING
#837Cell into which protein, which can serve as polymerization nucleus of protein polymer, or polymer thereof is introduced, and method for production of the cell
#838MODULATORS OF NEURONAL REGENERATION
#839METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES
#840GREEN TEA POLYPHENOL ALPHA SECRETASE ENHANCERS AND METHODS OF USE
#841METHODS TO EVALUATE GLUCOCORTICOID RECEPTOR AGONISTS AND ANTAGONISTS FOR EFFECTS ON NEURON-LIKE CELLS
#842Use of fused nicotinamides to promote neurogenesis
#843Methods for identifying agents that affect the survival of motor neurons
#844Light-inducible and rhythmically expressed genes and method for screening substances that affect an internal clock system
#845High throughput assays for transmissible spongiform encephalopathies (TSE)
#846Therapeutic Methods for Neuropathic Pain
#847Methods of generating mature oligodendrocytes
#848Use of Androgens for the Treatment of Parkinson's Disease
#849Nanobioelectronics
#850Immortalization of cells including neuronal cells
#851Multinetwork nerve cell assay platform with parallel recording capability
#852Method of making a molded food item from individual food pieces
#853Target for regulating multiple sclerosis
#854Compositions And Methods For Identifying Modulars Of TRPV2
#855Processing of EphA4 polypeptide by γ-secretase activity
#856Method for activation of transient receptor potential cation channel, subfamily A, member 1 using acetaldehyde
#857Stable neural stem cell lines
#858Cell cycle regulation and differentiation
#859Method of identifying therapeutic agents
#860Ion channel assay methods
#861Method and device for producing shaped meat portions from whole natural meat pieces
#862Modulators of neuronal regeneration
#863SCREENING METHOD FOR COMPOUNDS WITH ANAESTHETIC PROPERTY
#864METHODS AND MATERIALS RELATING TO ENHANCED PRODUCTION OF DOPAMINE NEURONS
#865LGI, LINGO and p75NTR family members: novel modulators of neuronal growth
#866Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro
#867Methods of identifying neuroprotective compounds for retinal ganglion cells
#868Methods for screening for inhibitors of TRPV2 activation
#869Benzimidazole-carboxamide compounds as 5-HTreceptor agonists
#870AGENTS FOR SUPPRESSING NEURAL FIBROTIC DEGENERATION
#871MICROTUBULE SYNTHESIS AS A BIOMARKER
#872Antibodies that specifically bind hedgehog-derived polypeptides
#873Methods of suppressing microglial activation and systemic inflammatory responses
#874METHODS OF SUPPRESSING MICROGLIAL ACTIVATION AND SYSTEMIC INFLAMMATORY RESPONSES
#875Modulators of neuronal regeneration
#876METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPB
#877Methods and compositions for treating brain diseases
#878Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-R
#879Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration
#880MODULATORS OF ODORANT RECEPTORS
#881Modulators of odorant receptors
#882Method of Measuring Amyloid-Beta Peptides
#883MOLECULES INVOLVED IN SYNAPTOGENESIS AND USES THEREFOR
#884METHODS USING THE GRUENEBERG GANGLION CHEMOSENSORY SYSTEM
#885Modulators that promote cell surface expression of odorant receptors
#886Methods of treating neurological conditions with hematopoeitic growth factors
#887123 Human Secreted Proteins
#888Method of identifying transmembrane protein-interacting compounds
#889Process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells
#890Method for treating a brain cancer with ifenprodil
#891Method of analyzing cell or the like having linear shape, method of analyzing nerve cell and apparatus and program for performing these methods
#892Cells and methods for estimation of effects on neurological dysfunction
#893MODULATION OF SYNAPTOGENESIS
#894NOVEL CHEMICAL ENTITIES AFFECTING NEUROBLASTOMA TUMOR-INITIATING CELLS
#895Modulation of synaptogenesis
#896Use of Sumoylation Inhibitors for the Treatment of Neurodegenerative Disease
#897METHOD AND TEST KIT FOR THE IDENTIFICATION OF COMPOUNDS SPECIFICALLY MODULATING THE ACTION OF CORTICAL AXO-AXONIC CELLS
#898Nucleic acid encoding apolipoprotein E-I3
#899Lineage Restricted Glial Precursors from the Central Nervous System
#900METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES USING NMDA RECEPTOR GLYCINE SITE ANTAGONISTS